Department of Cranio-, Maxillofacial and Oral Surgery, Medical University of Vienna, Waehringer Guertel 18-20, 1090, Vienna, Austria.
Clin Oral Investig. 2013 Apr;17(3):913-9. doi: 10.1007/s00784-012-0755-8. Epub 2012 May 29.
The aim of this study was to evaluate the postoperative platelet count changes in patients with oral and oropharyngeal squamous cell carcinoma undergoing preoperative chemoradiotherapy in order to test the hypothesis that the failure of platelets to recover to normal range within 7 days after surgery represents a significant risk factor for poor survival.
A cohort of 102 patients with primary locally advanced oral and oropharyngeal squamous cell carcinoma undergoing neoadjuvant chemoradiotherapy and surgery was retrospectively analyzed. For each patient, platelet counts were evaluated prior to neoadjuvant treatment, prior to surgery and throughout postoperative days 1 to 7. The Kaplan-Meier method and Cox regression models were used to assess the impact of platelet count changes on survival.
Overall survival rate at 5 years was 28% for patients whose platelets did not recover by day 7, with 52% for patients whose platelets remained within a normal level or recovered to this by day 7 (p = 0.005). In multivariate analysis, failure of platelet recovery by day 7 was independently associated with shorter overall survival (p = 0.03).
We demonstrated that the failure of platelets to recover to normal range by the seventh postoperative day is an independent adverse prognostic factor in patients with oral and oropharyngeal cancer undergoing neoadjuvant treatment and surgery.
Our results indicate that physicians should pay closer attention to monitoring the postoperative platelet count course, as it may predict the clinical outcome of patients with oral and oropharyngeal cancer.
本研究旨在评估接受术前放化疗的口腔和口咽鳞状细胞癌患者术后血小板计数的变化,以检验血小板在术后 7 天内未能恢复正常范围是生存不良的显著危险因素这一假设。
回顾性分析了 102 例接受新辅助放化疗和手术的原发性局部晚期口腔和口咽鳞状细胞癌患者的队列。对每位患者,在新辅助治疗前、手术前和术后第 1 至 7 天评估血小板计数。采用 Kaplan-Meier 方法和 Cox 回归模型评估血小板计数变化对生存的影响。
术后第 7 天血小板未恢复的患者 5 年总生存率为 28%,血小板水平正常或恢复至正常水平的患者为 52%(p=0.005)。多因素分析显示,术后第 7 天血小板未恢复与总生存时间缩短独立相关(p=0.03)。
我们证明了血小板在术后第 7 天未恢复至正常范围是接受新辅助治疗和手术的口腔和口咽癌患者的独立不良预后因素。
我们的结果表明,医生应更密切关注监测术后血小板计数过程,因为它可能预测口腔和口咽癌患者的临床结局。